Newly recognized as a clinical diagnosis, Lp (a) elevation is a major contributor to
cardiovascular disease risk should be considered for patients with advanced premature …

Background Elevated lipoprotein (a)(Lp (a)) is an inherited lipid disorder and an
independent risk factor for cardiovascular (CV) disease. Although its prevalence in the …

Introduction Lipoprotein (a)[Lp (a)] is a genetically determined independent risk factor for
atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease. Despite …

Lipoprotein (a)(Lp (a)) resembles low-density lipoprotein (LDL) in that it contains one
molecule of apolipoprotein (apo) B-100 and displays a high content of cholesteryl esters. Lp …

Abstract Elevated lipoprotein (a)(Lp [a]) is an independent, genetic risk factor for
atherosclerotic cardiovascular disease (ASCVD) that impacts~ 1.4 billion people globally …

Background Lipoprotein (a)[Lp (a)] is an inherited atherogenic lipoprotein and an
independent risk factor for atherosclerotic cardiovascular disease; however, its clinical role …

The role of lipoprotein (a)[Lp (a)] in the development of atherosclerosis has been recently
recognized, and the current recommendation is to measure Lp (a) once in a lifetime in all …

Atherosclerotic cardiovascular diseases (CVD) are still the leading cause of morbidity and
mortality worldwide, although optimal medical therapy has been prescribed for primary and …

Aims To validate the reported increased atherosclerotic cardiovascular disease (ASCVD)
risk associated with very high lipoprotein (a)[Lp (a)] and to investigate the impact of routine …

BACKGROUND: Elevated levels of lipoprotein (a)(Lp (a)) are independently associated with
an increased risk of atherosclerotic cardiovascular disease events. However, the …